nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—EDN1—Parkinson's disease	0.0228	0.0228	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—EDN1—Parkinson's disease	0.0223	0.0223	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.0193	0.0193	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.0189	0.0189	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.0172	0.0172	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.0169	0.0169	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Other—ADORA2A—Parkinson's disease	0.016	0.016	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.0149	0.0149	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—GRK5—Parkinson's disease	0.0146	0.0146	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.0146	0.0146	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—GRK5—Parkinson's disease	0.0143	0.0143	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.0131	0.0131	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Other—DRD3—Parkinson's disease	0.013	0.013	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.0128	0.0128	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.0128	0.0128	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.0125	0.0125	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Other—HTR7—Parkinson's disease	0.0117	0.0117	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—GRM5—Parkinson's disease	0.0106	0.0106	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—GRM5—Parkinson's disease	0.0103	0.0103	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GPR37—Parkinson's disease	0.00971	0.00971	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GPR37—Parkinson's disease	0.00951	0.00951	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.00944	0.00944	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.00924	0.00924	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00822	0.00822	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Other—HTR2A—Parkinson's disease	0.00821	0.00821	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00805	0.00805	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—TAC1—Parkinson's disease	0.00767	0.00767	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00752	0.00752	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—TAC1—Parkinson's disease	0.00751	0.00751	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00736	0.00736	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00694	0.00694	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00686	0.00686	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.0068	0.0068	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00679	0.00679	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00671	0.00671	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.00666	0.00666	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GRM4—Parkinson's disease	0.0066	0.0066	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GRM4—Parkinson's disease	0.00646	0.00646	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—PENK—Parkinson's disease	0.00626	0.00626	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—PENK—Parkinson's disease	0.00613	0.00613	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00608	0.00608	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00602	0.00602	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00595	0.00595	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00594	0.00594	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00589	0.00589	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00582	0.00582	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00581	0.00581	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—PDYN—Parkinson's disease	0.00573	0.00573	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00569	0.00569	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00563	0.00563	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—PDYN—Parkinson's disease	0.0056	0.0056	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00551	0.00551	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00549	0.00549	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00537	0.00537	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GRM5—Parkinson's disease	0.00532	0.00532	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00527	0.00527	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GRM5—Parkinson's disease	0.00521	0.00521	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00516	0.00516	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00516	0.00516	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00509	0.00509	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00509	0.00509	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00508	0.00508	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00505	0.00505	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GPR37—Parkinson's disease	0.00499	0.00499	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—DGKQ—Parkinson's disease	0.00499	0.00499	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00498	0.00498	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00498	0.00498	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00498	0.00498	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00497	0.00497	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00488	0.00488	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GPR37—Parkinson's disease	0.00488	0.00488	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00488	0.00488	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00482	0.00482	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00472	0.00472	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00472	0.00472	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00462	0.00462	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00461	0.00461	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00456	0.00456	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00453	0.00453	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00452	0.00452	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00446	0.00446	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00443	0.00443	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00436	0.00436	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00436	0.00436	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00427	0.00427	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00427	0.00427	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GRK5—Parkinson's disease	0.00416	0.00416	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00413	0.00413	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00407	0.00407	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00404	0.00404	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—HTR1A—Parkinson's disease	0.00393	0.00393	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—TAC1—Parkinson's disease	0.00387	0.00387	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00384	0.00384	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—DRD1—Parkinson's disease	0.00379	0.00379	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—TAC1—Parkinson's disease	0.00379	0.00379	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GRK5—Parkinson's disease	0.00378	0.00378	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GRM4—Parkinson's disease	0.00373	0.00373	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—DRD1—Parkinson's disease	0.00371	0.00371	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GRK5—Parkinson's disease	0.0037	0.0037	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—DRD3—Parkinson's disease	0.00367	0.00367	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00365	0.00365	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—DRD3—Parkinson's disease	0.0036	0.0036	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00357	0.00357	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—VPS35—Parkinson's disease	0.00355	0.00355	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PENK—Parkinson's disease	0.00354	0.00354	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00349	0.00349	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00349	0.00349	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—VPS35—Parkinson's disease	0.00348	0.00348	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PENK—Parkinson's disease	0.00346	0.00346	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00342	0.00342	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GRM4—Parkinson's disease	0.00339	0.00339	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—DRD2—Parkinson's disease	0.00332	0.00332	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—HTR7—Parkinson's disease	0.00332	0.00332	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GRM4—Parkinson's disease	0.00332	0.00332	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—DRD2—Parkinson's disease	0.00325	0.00325	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—HTR7—Parkinson's disease	0.00325	0.00325	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PDYN—Parkinson's disease	0.00324	0.00324	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PENK—Parkinson's disease	0.00321	0.00321	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00317	0.00317	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PENK—Parkinson's disease	0.00314	0.00314	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00306	0.00306	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GRM5—Parkinson's disease	0.00301	0.00301	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00299	0.00299	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GPR37—Parkinson's disease	0.00295	0.00295	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DGKQ—Parkinson's disease	0.00295	0.00295	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00294	0.00294	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PDYN—Parkinson's disease	0.00294	0.00294	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DGKQ—Parkinson's disease	0.00288	0.00288	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GPR37—Parkinson's disease	0.00288	0.00288	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PDYN—Parkinson's disease	0.00288	0.00288	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GRM5—Parkinson's disease	0.00273	0.00273	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00269	0.00269	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GRM5—Parkinson's disease	0.00267	0.00267	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—EDN1—Parkinson's disease	0.00266	0.00266	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00264	0.00264	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—EDN1—Parkinson's disease	0.0026	0.0026	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00256	0.00256	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.0025	0.0025	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RIT2—Parkinson's disease	0.00235	0.00235	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—HTR2A—Parkinson's disease	0.00233	0.00233	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00232	0.00232	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RIT2—Parkinson's disease	0.0023	0.0023	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00228	0.00228	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00227	0.00227	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GRK5—Parkinson's disease	0.00223	0.00223	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00222	0.00222	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—TAC1—Parkinson's disease	0.00219	0.00219	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GRK5—Parkinson's disease	0.00218	0.00218	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00217	0.00217	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—DRD1—Parkinson's disease	0.00214	0.00214	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—TAC1—Parkinson's disease	0.00214	0.00214	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—DRD1—Parkinson's disease	0.0021	0.0021	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—DRD3—Parkinson's disease	0.00208	0.00208	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—DRD3—Parkinson's disease	0.00203	0.00203	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—HTR1A—Parkinson's disease	0.00202	0.00202	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GRM4—Parkinson's disease	0.002	0.002	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—TAC1—Parkinson's disease	0.00198	0.00198	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—HTR1A—Parkinson's disease	0.00197	0.00197	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GRM4—Parkinson's disease	0.00196	0.00196	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—DRD1—Parkinson's disease	0.00195	0.00195	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—TAC1—Parkinson's disease	0.00194	0.00194	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00194	0.00194	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—DRD1—Parkinson's disease	0.00191	0.00191	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PENK—Parkinson's disease	0.0019	0.0019	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MAG—Parkinson's disease	0.0019	0.0019	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.0019	0.0019	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—DRD3—Parkinson's disease	0.00189	0.00189	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—HTR7—Parkinson's disease	0.00188	0.00188	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—DRD2—Parkinson's disease	0.00188	0.00188	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PENK—Parkinson's disease	0.00186	0.00186	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MAG—Parkinson's disease	0.00186	0.00186	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—DRD3—Parkinson's disease	0.00185	0.00185	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—DRD2—Parkinson's disease	0.00184	0.00184	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—HTR7—Parkinson's disease	0.00184	0.00184	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00176	0.00176	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PDYN—Parkinson's disease	0.00174	0.00174	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00172	0.00172	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—DRD2—Parkinson's disease	0.0017	0.0017	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—HTR7—Parkinson's disease	0.0017	0.0017	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PDYN—Parkinson's disease	0.0017	0.0017	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—DRD2—Parkinson's disease	0.00167	0.00167	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—HTR7—Parkinson's disease	0.00167	0.00167	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GFAP—Parkinson's disease	0.00163	0.00163	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GRM5—Parkinson's disease	0.00161	0.00161	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GFAP—Parkinson's disease	0.0016	0.0016	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GRM5—Parkinson's disease	0.00158	0.00158	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—EDN1—Parkinson's disease	0.0015	0.0015	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—EDN1—Parkinson's disease	0.00147	0.00147	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.00143	0.00143	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FGF20—Parkinson's disease	0.00141	0.00141	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.0014	0.0014	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FGF20—Parkinson's disease	0.00139	0.00139	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADORA2A—Parkinson's disease	0.00137	0.00137	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—EDN1—Parkinson's disease	0.00136	0.00136	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADORA2A—Parkinson's disease	0.00134	0.00134	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—EDN1—Parkinson's disease	0.00134	0.00134	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00131	0.00131	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00129	0.00129	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—INSR—Parkinson's disease	0.00127	0.00127	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—INSR—Parkinson's disease	0.00124	0.00124	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FGB—Parkinson's disease	0.0012	0.0012	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—HTR2A—Parkinson's disease	0.00119	0.00119	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HTR1A—Parkinson's disease	0.00119	0.00119	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TAC1—Parkinson's disease	0.00117	0.00117	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FGB—Parkinson's disease	0.00117	0.00117	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—HTR2A—Parkinson's disease	0.00117	0.00117	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HTR1A—Parkinson's disease	0.00117	0.00117	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DRD1—Parkinson's disease	0.00115	0.00115	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TAC1—Parkinson's disease	0.00115	0.00115	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DRD1—Parkinson's disease	0.00113	0.00113	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DRD3—Parkinson's disease	0.00111	0.00111	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DRD3—Parkinson's disease	0.00109	0.00109	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADRBK1—Parkinson's disease	0.00104	0.00104	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADRBK1—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—DRD2—Parkinson's disease	0.00101	0.00101	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HTR7—Parkinson's disease	0.00101	0.00101	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HTR7—Parkinson's disease	0.000986	0.000986	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—DRD2—Parkinson's disease	0.000986	0.000986	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IGF2—Parkinson's disease	0.000844	0.000844	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IGF2—Parkinson's disease	0.000826	0.000826	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IGF1R—Parkinson's disease	0.000816	0.000816	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EDN1—Parkinson's disease	0.000806	0.000806	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IGF1R—Parkinson's disease	0.000799	0.000799	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EDN1—Parkinson's disease	0.000789	0.000789	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NGF—Parkinson's disease	0.000741	0.000741	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NGF—Parkinson's disease	0.000725	0.000725	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HTR2A—Parkinson's disease	0.000705	0.000705	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HTR2A—Parkinson's disease	0.00069	0.00069	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APOE—Parkinson's disease	0.000656	0.000656	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APOE—Parkinson's disease	0.000642	0.000642	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—INS—Parkinson's disease	0.00056	0.00056	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—INS—Parkinson's disease	0.000548	0.000548	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CASP3—Parkinson's disease	0.000417	0.000417	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL6—Parkinson's disease	0.000414	0.000414	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CASP3—Parkinson's disease	0.000408	0.000408	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL6—Parkinson's disease	0.000406	0.000406	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MAPK8—Parkinson's disease	0.000383	0.000383	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MAPK8—Parkinson's disease	0.000375	0.000375	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL6—Parkinson's disease	0.000245	0.000245	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL6—Parkinson's disease	0.00024	0.00024	CbGpPWpGaD
